Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Dr. Ben Weston, chief health policy advisor for Milwaukee County, joins Lake Effect's Joy Powers to talk about how you can ...

Illinois had at least 103 outbreaks of the stomach bug norovirus in November and December – a dramatic increase from previous ...

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. But there are things ...

DOCTOR EMMA JOINS US WITH HIS ADVICE AND HOW TO PROTECT YOUR FAMILY FROM THE NOROVIRUS IS ONE OF THE MOST CONTAGIOUS FOODBORNE ILLNESSES. THERE’S NO TREATMENT FOR IT AND NO VACCINE. IT CAUSES ...